Mark Hagemann is a seasoned professional in finance, M&A, business development, and venture investing. They have held prominent roles such as Senior Director of M&A, Venture Investments, and Business Development at Quest Diagnostics from 2019 to 2025, and currently serve as the Head of Corporate Development at RVO Health. Previously, Mark worked as an Associate at King Street Capital Management, an Analyst at Barclays, and a Senior Manager at Pinnacle Foods. Mark earned an MBA from the University of Virginia Darden School of Business and has completed additional studies in entrepreneurship and innovation at the Stockholm School of Economics and IESE Business School, as well as a Bachelor's degree in Accounting and Finance from Villanova University.
This person is not in any teams
This person is not in any offices